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Summary
 
Although dendritic cell (DC) activation is a critical event for the induction of immune responses,
the signaling pathways involved in this process have not been characterized. In this report, we
show that DC activation induced by lipopolysaccharide (LPS) can be separated into two distinct
processes: first, maturation, leading to upregulation of MHC and costimulatory molecules, and sec-
ond, rescue from immediate apoptosis after withdrawal of growth factors (survival). Using a DC
culture system that allowed us to propagate immature growth factor–dependent DCs, we have in-
vestigated the signaling pathways activated by LPS. We found that LPS induced nuclear transloca-
tion of the nuclear factor (NF)-
 
k
 
B transcription factor. Inhibition of NF-
 
k
 
B activation blocked
maturation of DCs in terms of upregulation of major histocompatibility complex and costimula-
tory molecules. In addition, we found that LPS activated the extracellular signal–regulated kinase
(ERK), and that specific inhibition of MEK1, the kinase which activates ERK, abrogated the ability
of LPS to prevent apoptosis but did not inhibit DC maturation or NF-
 
k
 
B nuclear translocation.
These results indicate that ERK and NF-
 
k
 
B regulate different aspects of LPS-induced DC activa-
tion: ERK regulates DC survival whereas NF-
 
k
 
B is responsible for DC maturation.
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D
 
endritic cells (DCs) are now recognized as major
players in the regulation of immune responses to a va-
riety of antigens, including bacterial and viral agents (1).
DCs direct both the quality and the extent of the immune
response, but the ability of DCs to activate naive T cells
depends on their maturation. Fully mature DCs have a
high surface expression of MHC and costimulatory mole-
cules and are located in lymphoid organs. In contrast, im-
mature DCs are mainly distributed in tissues interfacing
with the external environment where they capture and
process antigens with high efficiency (1). After microbe in-
ternalization and inflammation, DC leave the tissue to
reach the lymphoid organs. During this migration the DC
undergo maturation and acquire the ability to prime T
cells. This second functional stage is irreversible and is fol-
lowed by apoptosis (2). Among the inflammatory signals
that induce DC maturation, LPS, a Gram-negative bacte-
rial cell wall component, has been shown to fully activate
DC both in vitro and in vivo (2–4).
To oppose bacterial infections and inflammation, DCs
have to respond rapidly to changes in their microenviron-
ment. Most types of signals induce cellular responses by
binding to specific cell-surface receptors that respond to
occupancy by triggering one or more signal transduction
pathways (5). One of the most common responses to re-
ceptor engagement is the activation of transcription factors
and the synthesis of new proteins. Among the transcription
factors, the active heterodimer p50/p65 form of nuclear
factor (NF)-
 
k
 
B plays a central role in immunological pro-
cesses by inducing expression of a variety of genes involved
in inflammatory responses (6). In macrophages, NF-
 
k
 
B can
be activated by exposure to LPS as well as by inflammatory
cytokines (TNF-
 
a
 
 and IL-1) and viral infections (7–9).
Mature DCs express high levels of the NF-
 
k
 
B family of
transcription factors (10) and signaling by members of the
TNF-
 
a
 
 receptor family, such as CD40 and RANK, results
in activation of NF-
 
k
 
B (1). Other transcription factors are
regulated by signal transduction pathways that involve en-
zymatic cascades of mitogen-activated protein (MAP) ki-
nases. The latter are activated by many receptors, as well as
by environmental stresses, and have been shown to mediate
both mitogenic and apoptotic responses (11–14). LPS has
been shown to activate the extracellular signal–regulated
kinase, c-Jun NH
 
2
 
-terminal kinase (JNK), and p38 MAP
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kinases in murine macrophages (15–17) but, to date, the
signal transduction pathways activated during DC matura-
tion have not been characterized.
In vitro studies of immature mouse DCs have been ham-
pered because it has not been possible to arrest spontaneous
DC maturation and cell death (18). Recently, we have de-
scribed a DC culture system (D1 cells) that allows us to
maintain the immature DC phenotype in vitro. DC prolif-
eration is growth factor dependent, and maturation can be
induced by inflammatory signals and by bacteria (2, 19),
thus mimicking the in vivo response (3). Survival of the
immature D1 cells is maintained by a mixture of cytokines
contained in the DC conditioned medium (CM). Depriva-
tion of CM causes D1 cells to undergo apoptotic cell death
within 48 h. Using this unique system, we were able to in-
vestigate the kinetics of DC maturation and survival and to
identify some of the molecular events involved in these
processes. Here it is shown that, in addition to inducing
DC maturation, LPS arrests DC proliferation and promotes
DC survival after CM deprivation. We also found that LPS
activates both the ERK MAP kinase and the NF-
 
k
 
B tran-
scription factor. The two signal transduction pathways are
independent and regulate different aspects of LPS-induced
DC activation.
 
Materials and Methods
 
Cells and Reagents.
 
The D1 cells were derived from murine
splenic DCs and maintained in vitro as growth factor–dependent
immature DCs (2, 19). D1 cells were grown in complete IMDM
supplemented with 30% R1 CM containing 30 ng/ml GM-CSF
as previously described (2).
LPS (
 
Escherichia coli
 
 serotype 026:B6)
 
 
 
and 
 
N
 
-tosyl-
 
l
 
-phen-
ylalanine chloromethyl ketone (TPCK) were purchased from
Sigma Chemical Co. (St. Louis, MO). MEK inhibitor PD98059
was from BIOMOL Research Labs., Inc. (Plymouth Meeting, PA).
 
Cell Stimulation and Preparation of Cell Lysates.
 
5 
 
3 
 
10
 
6
 
 D1
cells were resuspended in 1 ml of modified Hepes-buffered saline
(20), warmed to 37
 
8
 
C, and stimulated with LPS (10 
 
m
 
g/ml) for the
indicated times. Where indicated, the cells were pretreated at 37
 
8
 
C
with 50 or 100 
 
m
 
M MEK inhibitor PD98059 for 30 min or with
15 
 
m
 
M TPCK for 1.5 h before being stimulated with LPS. Reac-
tions were stopped by adding ice-cold PBS containing 1 mM
Na
 
3
 
VO
 
4
 
 and then centrifuging the cells for 3 min in the cold. The
cells were pelleted and then solubilized in buffers containing 1%
Triton X-100 or NP-40 as well as protease and phosphatase inhib-
itors. Detergent-insoluble material was removed by centrifugation.
 
In Vitro Kinase Assays.
 
In vitro kinase assays for ERK, JNK,
and MAP kinase–activated protein (MAPKAP) kinase-2 have
been described previously (21). For ERK assays, lysates from 5 
 
3
 
10
 
6 
 
D1 cells were immunoprecipitated with an agarose-conju-
gated antibody that recognizes ERK2, and to a lesser extent
ERK1 (antibody C-14; Santa Cruz Biotechnology Inc., Santa
Cruz, CA). For JNK and MAPKAP kinase-2 assays, lysates from
5 
 
3 
 
10
 
6 
 
D1 cells were immunoprecipitated with an antibody to
either JNK1 (antibody C-17; Santa Cruz Biotechnology) or
MAPKAP kinase-2 (Upstate Biotechnology Inc., Lake Placid,
NY) and immune complexes were collected on protein A–Seph-
arose (Sigma Chemical Co.). After washing, immune complexes
were incubated with 
 
32
 
P-
 
g
 
-ATP and either myelin basic protein
(MBP; Sigma Chemical Co.) for ERK assays, a glutathione
 
S
 
-transferase (GST)–c-Jun fusion protein (21) for JNK assays,
or recombinant hsp 25 (StressGen, Victoria, British Columbia,
Canada) for MAPKAP kinase-2 assays. The samples were sepa-
rated by SDS-PAGE and the transfer of 
 
32
 
P to the substrates
was quantitated using a PhosphorImager (Molecular Dynamics,
Sunnyvale, CA).
 
Assessment of Apoptosis by Flow Cytometry.
 
Cells were prein-
cubated or not with 50 
 
m
 
M PD98059 for 30 min and then with
10 
 
m
 
g/ml LPS for 8, 24, or 48 h. Cells were detached, double
stained with FITC-conjugated Annexin V (PharMingen, San Di-
ego, CA) and 1.25 
 
m
 
g/ml propidium iodide (Sigma Chemical
Co.), and analyzed by flow cytometry.
 
Antibodies, Cytokine Assays, and Flow Cytometry Analysis.
 
At
different time points after LPS activation, Dl cells were detached
with PBS/2 mM EDTA and incubated with one of the following
mAbs: anti-(I-A
 
d
 
/I-E
 
d
 
) or anti-CD86 (B7.2; PharMingen). Stain-
ing was carried out in the presence of 2-4G2 (anti-CD32) anti-
body supernatant to block Fc receptor binding. The cells were
washed and analyzed using the FACScan
 
Ò
 
 (Becton Dickinson,
San Jose, CA). Culture supernatants were collected 24 h after
treatment with LPS in the presence or absence of indicated con-
centrations of PD98059, and TNF-
 
a
 
 was measured by TNF-
 
a
 
DuoSet ELISA following manufacturer’s instructions (Genzyme
Corp., Cambridge, MA).
 
NF-
 
k
 
B Nuclear Translocation.
 
D1 cells were pretreated or not
with 50 
 
m
 
M MEK inhibitor or 15 
 
m
 
M TPCK and activated with
LPS (10 
 
m
 
g/ml) for 30 min, 1 h, or 4 h. Cells were then washed
and plated on poly-
 
l
 
-Lysine–treated coverslips and processed for
immunofluorescence. Coverslips were stained with rabbit anti-
p65 (Rel A), purchased from Santa Cruz Biotechnology. Anti–
rabbit CY3 conjugate was from Nycomed Amersham plc (Little
Chalfont, Buckinghamshire, UK).
 
Results and Discussion
 
LPS Induces both Survival and Maturation of DC.
 
Murine
Langerhans cells purified from the skin as well as bone mar-
row–derived DCs have a limited life-span in culture even
in the presence of granulocyte-macrophage colony stimu-
lating factor (1). Cultured DCs undergo spontaneous matu-
ration and cell death (18). We have described a DC culture
system (D1 cells) that allows us to maintain the immature
DC phenotype in vitro. Growth of D1 cells is supported by
a pool of cytokines present in CM. We have previously
shown that incubation of D1 cells with LPS induced func-
tional maturation of the cells (2), here we have shown that
it also arrests the cell cycle, and promotes survival after CM
deprivation (Fig. 1). More than 50% of the cells were still
viable 5 d after growth-factor withdrawal, whereas in the
absence of LPS, cells died within 48 h. This indicates that
LPS promotes survival of DCs.
 
LPS Activates ERK Kinases.
 
To understand the molec-
ular mechanisms involved in DC maturation, we investi-
gated the signaling pathways activated by LPS in D1 cells.
MAP kinases are activated by many receptors, as well as by
environmental stresses, and have been shown to mediate
both mitogenic and apoptotic responses (11–14). There are
three main families of MAP kinases that are involved in sig-
nal transduction, the ERKs, the JNKs, and the p38 kinases. 
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These kinases are activated by MAP kinase kinases (MKKs),
which phosphorylate threonine and tyrosine residues in the
Thr-X-Tyr activation motif (22, 23). Upon activation,
MAP kinases can migrate to the nucleus where they phos-
phorylate and activate transcription factors. Each MAP
kinase family targets a different set of transcription factors.
Since LPS has been shown to activate the ERK, JNK,
and p38 MAP kinases in murine macrophages (15–17), we
investigated whether LPS activated MAP kinases in the D1
cells. The D1 cells were incubated with LPS and in vitro
kinase assays were performed to measure the activity of
ERK1/2, JNK1, and MAPKAP kinase-2, a downstream
target of the p38 MAP kinase. We chose to assay MAP-
KAP kinase-2 activity instead of directly assaying p38 MAP
kinase activity since the MAPKAP kinase-2 assay is more
sensitive. Activation of MAPKAP kinase-2 has been shown
to be entirely dependent on p38 activation (reference 24;
Sutherland, C.L., and M.R. Gold, unpublished results).
We found that exposing D1 cells to LPS for 15 min re-
sulted in a fivefold activation of the ERK MAP kinases
(Fig. 2). In contrast, LPS caused very little activation
(
 
z
 
1.5-fold stimulation) of the JNK MAP kinase and only
modest activation (2–2.5-fold stimulation) of MAPKAP ki-
nase-2. Thus, the ERK MAP kinases appear to be the ma-
jor MAP kinase target of LPS signaling in D1 cells.
 
ERK Is Involved in DC Survival but not Maturation during
LPS Treatment.
 
To evaluate the role of ERK in both DC
survival and DC maturation, we investigated the effect of a
highly selective inhibitor of the ERK pathway on D1 cells.
PD98059 (25) is a specific inhibitor of MEK1, the kinase
that phosphorylates and activates the ERK kinases.
 
 
 
DC
maturation correlates with the upregulation of a panel of
surface markers including MHC and costimulatory mole-
cules. We found that pretreating D1 cells with the MEK
inhibitor PD98059 had no effect on the ability of LPS to
increase the surface expression of MHC and costimulatory
molecules (Fig. 3 
 
A
 
). Thus ERK activation is not involved
in DC maturation.
In contrast, we found that MEK activity was essential for
DC survival. We found that the ability of LPS to prevent
apoptosis of D1 cells was dramatically reduced when the
cells were pre-treated with the MEK inhibitor PD98059
(Fig. 3 
 
B
 
). Apoptosis of D1 cells due to growth factor with-
drawal was analyzed using annexin V-FITC, which detects
the appearance of the early apoptotic marker phosphati-
dylserine on the cell surface. D1 cells cultured in medium
alone, in the absence of CM, underwent rapid apoptosis
with 20% of the cells binding annexin V-FITC after 8 h
(data not shown). In the presence of LPS, the number of
apoptotic D1 cells was reduced to 
 
,
 
5% after 24 h and
 
z
 
18% after 48 h (Fig. 3 
 
B
 
). However, when the D1 cells
were pretreated with the MEK inhibitor, the ability of LPS
to prevent apoptosis was greatly reduced with 25% of the
cell becoming apoptotic after 24 h and nearly 50% being
apoptotic after 48 h (Fig. 3 
 
B
 
). The same feature was ob-
served when viability of the cells was analyzed at different
time points (Fig. 3 
 
B
 
, 
 
inset
 
). Although PD98059 blocked
the ability of LPS to prevent apoptosis of D1 cells, it did
not block the ability of CM to prevent apoptosis. This
shows that PD98059 is not toxic to the D1 cells, that its
ability to block LPS-induced survival of D1 cells is a spe-
cific effect, and that the ability of CM to prevent D1 cell
apoptosis does not depend on the MEK/ERK pathway.
Thus, activation of the MEK/ERK pathway is required for
LPS, but not CM, to prevent apoptosis of D1 cells due to
growth factor withdrawal. The role of ERK in promoting
the survival of D1 cells is consistent with the finding that
ERK activation is also essential for preventing apoptosis of
PC-12 cells after growth factor withdrawal (14).
Figure 1. LPS induces growth
arrest and survival of D1 cells af-
ter CM deprivation. Cells were
incubated either in medium or
CM with or without 10 mg/ml
of LPS for the indicated times.
The number of viable cells re-
maining at the different time
points is shown as a percentage
of the cells seeded at time 0.
Figure 2. Activation of MAP
kinases by LPS. D1 cells were in-
cubated with or without 10 mg/
ml LPS for 15 min. As a positive
control for activation of the
stress-activated MAP kinase path-
ways (the JNK and p38/MAP-
KAP kinase-2 pathways), D1 cells
were exposed to high osmolarity
conditions by treating them with
0.6 M sorbitol for 15 min. In vitro
kinase assays were performed us-
ing MBP as a substrate for ERK,
GST–c-Jun as a substrate for
JNK, and hsp25 as a substrate for
MAPKAP kinase-2. (A) MAP
kinase activities relative to those in unstimulated cells (defined as 1.0). The transfer of 32P to the various substrates was quantitated with a PhosphorImager.
The data represent the average and range of two independent experiments. (B) Representative autoradiographs of the in vitro kinase assays for ERK,
JNK, and MAPKAP kinase-2. Lane 1, unstimulated cells; lane 2, LPS-stimulated cells; lane 3, sorbitol-treated cells. 
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ERK Activation Is Necessary to Promote TNF-
 
a
 
 Production.
 
Since TNF-
 
a
 
 has been shown to maintain the viability of
Langerhans cells in culture (26), we investigated whether
the MEK inhibitor blocked the ability of LPS to stimulate
TNF-
 
a
 
 production by D1 cells. Fig. 3 
 
C
 
 shows that LPS
causes a large increase in TNF-
 
a
 
 release by D1 cells but
that this response is substantially reduced in the presence of
the MEK inhibitor PD98059. Thus, TNF-
 
a
 
 production
correlates with DC viability and the ability of LPS to pre-
vent apoptosis of D1 cells.
 
LPS Induces Nuclear Translocation of NF-
 
k
 
B.
 
Experiments
using the MEK inhibitor PD98059 showed that the MEK/
ERK pathway is essential for LPS to promote DC survival
but not for LPS-induced DC maturation. To elucidate the
signaling requirements for LPS-induced DC maturation,
we investigated whether NF-
 
k
 
B is
 
 
 
involved in this matura-
tion program. The NF-
 
k
 
B transcription factor (p50-p65) is
the prototype of a family of homodimeric and hetero-
dimeric protein complexes comprised of subunits related to
the c-rel protooncogene. Five mammalian proteins of the
Rel/NF-
 
k
 
B family, NF-
 
k
 
B1 (p50, p105), NF-
 
k
 
B2 (p52,
p100), Rel A (p65), Rel B, and Rel have been described so
far (for review see references 27, 28). These proteins are
widely expressed and regulate transcription by binding to
decameric sequences (
 
k
 
B motifs) that control transcription,
particularly of proteins involved in immune and inflamma-
tory responses (6, 29). Before stimulation, Rel/NF-
 
k
 
B is
retained in the cytoplasm in an inactive form due to its
binding to the inhibitor (I
 
k
 
B) proteins (27). In response to
a number of different stimuli, I
 
k
 
B is first phosphorylated
and then ubiquitinated and targeted to the proteasome for
degradation. This allows Rel/NF-
 
kB to translocate to the
nucleus and activate transcription of target genes.
Mature DCs express high levels of the NF-kB family of
transcription factors (10) and signaling by members of the
TNF-a receptor family, such as CD40 and RANK, results
in activation of NF-kB (1). We found that a small propor-
tion of activated Rel A protein was present in the nucleus
of immature D1 cells, but that a 30-min treatment with
LPS induced massive translocation of the p65 molecule to
the nucleus (Fig. 4, A and B). LPS-induced nuclear translo-
cation of p65 was not blocked by the MEK inhibitor, indi-
cating that NF-kB activation does not depend on the
MEK/ERK pathway (Fig. 4 C). This is consistent with re-
cent findings that activation of NF-kB by TNF-a or IL-1
involves the NF-kB inducing kinase (NIK)/IKK kinase
complex (27, 30), which is independent of the ERK path-
way. This pathway is of particular interest because the
number of catalytic steps is minimized in order to reduce
the chances that low molecular weight metabolites such as
those produced by microorganisms can suppress the im-
mune response (27). Nevertheless, a recent report has
shown that bacteria of the Yersinia enterocolitica strain can
modulate the immune response of the host by interfering
with activation of NF-kB transcription factor in J774 mac-
rophage cell line (31). This strategy is used by the bacteria
to suppress TNF-a production and this contributes to trig-
ger macrophage cell death by apoptosis.
NF-kB Activation Is Responsible for DC Maturation. To test
whether activation of NF-kB is involved in LPS-induced
DC maturation, we used the serine protease inhibitor
TPCK, which blocks nuclear translocation of Rel/NF-kB by
preventing IkB-a degradation. Chloromethyl ketones such
as TPCK have been shown to block NF-kB–dependent
nitric oxide synthase in murine macrophages (32) and to
induce apoptosis in murine B cells (33) by preventing Rel/
Figure 3. MEK inhibitor does not influence maturation but induces apoptosis of DCs. (A) Flow cytometric analysis of B7.2 and MHC class II in D1
cells. Cells were preincubated or not with 50 mM PD98059 for 30 min and then treated with 10 mg/ml of LPS for 24 h in medium alone (IMDM 1 10%
FCS). Histograms: black, treated cells; white, untreated cells; broken outline, isotype control. (B) DCs were incubated with 10 mg/ml LPS in the presence or
absence of 50 mM PD98059 (I) in medium alone or with or without 50 mM PD98059 in CM. Cells were double stained with annexin V-FITC and pro-
pidium iodide and analysed by flow cytometry. Percentage of single positive cells for annexin V-FITC has been plotted. In the inset the number of viable
cells remaining at the different time points is shown as a percentage of the cells seeded at time 0. (C) TNF-a production induced by LPS is inhibited by
PD98059. Cells were preincubated with 50 or 100 mM inhibitor (I) and then treated for 24 h with 10 mg/ml LPS. Culture supernatants were tested by
ELISA for the presence of TNF-a.2179 Rescigno et al. Brief Definitive Report
NF-kB translocation to the nucleus. We found that TPCK
effectively blocked LPS-induced nuclear translocation of
p65 (data not shown). Functionally, this correlated with in-
hibition of LPS-induced D1 cell maturation in that the
ability of LPS to increase the cell surface expression of
MHC and costimulatory molecules was blocked by TPCK
treatment (Fig. 4 D). Inhibition of LPS-induced DC matu-
ration by TPCK was dose dependent, with maximal inhi-
bition at 20 mM TPCK. However, this dose of TPCK de-
creased the viability of immature D1 cells, suggesting a role
for other members of the Rel/NF-kB family in the growth
factor–dependent survival of these cells. Consistent with
this idea, a role for Rel B in the constitutive expression of
kB-containing housekeeping genes in DCs has been pro-
posed based on studies done on rel B knockout mice (34,
35). Furthermore, a recent report has shown that in B lym-
phocytes NF-kB1 and c-Rel are used differently to regu-
late apoptosis and cell cycle progression in resting and acti-
vated cells (36).
DCs have the unique ability to sense the external world
by capturing antigens. In the presence of inflammatory sig-
nals, maturing DCs abandon the inflamed site and reach the
draining lymph node. During this process, DCs have to ini-
tiate two differentiation responses, one being maturation
(upregulation of surface MHC and costimulatory molecules)
and the other being survival in a growth-arrested state in the
absence of growth factors. We have shown that LPS can
promote both of these differentiation responses but that the
two processes are mediated by different, independent signaling
pathways. The ability of LPS to promote DC survival in the
absence of growth factors is dependent on the MEK/ERK
pathway, whereas the ability of LPS to induce DC maturation,
in terms of upregulation of MHC II and B7.2, is dependent
on nuclear translocation of the NF-kB transcription factor.
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